1 - 10 of 163
Healthy control children are needed to help participate in a study on Immunometabolic Dysregulation.
The goal of this study is to identify unique characteristics in the way kids and teens with Autism Spectrum Disorder (ASD) speak in comparison to typically developing peers.
The Children’s Hospital of Philadelphia is seeking healthy adolescents between the ages of 12-13, who are currently in the 7th grade, to participate in the Sleep and Growth Study 2.
The Division of Rheumatology at CHOP is looking to engage healthy participants for several research studies with the goal of learning more about ways to improve the health and well-being of children and young adults.
Glomerular disease is a major cause of chronic kidney disease associated with substantial morbidity; children and adults with glomerular disease face many threats to bone health.
The overall goals of this study are to evaluate the side effects and benefits of CUDC-907 in patients with relapsed or treatment refractory solid tumor, brain tumor, or lymphoma, and to determine the best dose of CUDC-907 for children and adolescents
The overall goals of this study are to find the best dose of bosutinib that we can give safely, and to find out what effects, good and/or bad, bosutinib has on children and adolescents with Chronic Myeloid Leukemia (CML).
The goal of the study is to see if an experimental study formula helps children with cow's milk allergies and how children feel when consuming the formula. Participants with cow's milk allergy will take part in two food challenges. The food challenges are double-blinded placebo controlled which means that you and the study doctor won't know whether you are receiving the study formula or a placebo which is a formula that does not have any active ingredients in it. Participants will then drink the experimental study formula for 7 days . Families will be asked questions about their experience with the home feeding of the study formula. Participants requiring or preferring an extensively hydrolyzed formula will be allowed to continue on the experimental formula for free for 6 additional months. The study staff will contact you by phone each month during the 6-month period to see how you are feeling, how much you are consuming, and to check your weight.
Parents and their child between 16 and 18 who recently received their learner’s permit are both asked to partner with us for this study as we learn more about teen driving safety. We are looking for children both with and without an ADHD diagnosis to participate.
The purpose of this study is to find out if alpelisib (BYL719; the “study drug”), is safe and effective (can help) people who have PIK3CA-related overgrowth spectrum (PROS) disease.